These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. FRET-based sensors for the human M1-, M3-, and M5-acetylcholine receptors. Ziegler N; Bätz J; Zabel U; Lohse MJ; Hoffmann C Bioorg Med Chem; 2011 Feb; 19(3):1048-54. PubMed ID: 20716489 [TBL] [Abstract][Full Text] [Related]
3. Critical amino acid residues of the common allosteric site on the M2 muscarinic acetylcholine receptor: more similarities than differences between the structurally divergent agents gallamine and bis(ammonio)alkane-type hexamethylene-bis-[dimethyl-(3-phthalimidopropyl)ammonium]dibromide. Huang XP; Prilla S; Mohr K; Ellis J Mol Pharmacol; 2005 Sep; 68(3):769-78. PubMed ID: 15937215 [TBL] [Abstract][Full Text] [Related]
4. Oligomeric size of the m2 muscarinic receptor in live cells as determined by quantitative fluorescence resonance energy transfer. Pisterzi LF; Jansma DB; Georgiou J; Woodside MJ; Chou JT; Angers S; Raicu V; Wells JW J Biol Chem; 2010 May; 285(22):16723-38. PubMed ID: 20304928 [TBL] [Abstract][Full Text] [Related]
5. Interactions of orthosteric and allosteric ligands with [3H]dimethyl-W84 at the common allosteric site of muscarinic M2 receptors. Tränkle C; Weyand O; Voigtländer U; Mynett A; Lazareno S; Birdsall NJ; Mohr K Mol Pharmacol; 2003 Jul; 64(1):180-90. PubMed ID: 12815174 [TBL] [Abstract][Full Text] [Related]
6. Allosteric site in M2 acetylcholine receptors: evidence for a major conformational change upon binding of an orthosteric agonist instead of an antagonist. Grossmüller M; Antony J; Tränkle C; Holzgrabe U; Mohr K Naunyn Schmiedebergs Arch Pharmacol; 2006 Jan; 372(4):267-76. PubMed ID: 16362429 [TBL] [Abstract][Full Text] [Related]
7. Identification of a [3H]Ligand for the common allosteric site of muscarinic acetylcholine M2 receptors. Tränkle C; Mies-Klomfass E; Cid MH; Holzgrabe U; Mohr K Mol Pharmacol; 1998 Jul; 54(1):139-45. PubMed ID: 9658199 [TBL] [Abstract][Full Text] [Related]
8. Regulation of M2 muscarinic acetylcholine receptor expression and signaling by prolonged exposure to allosteric modulators. May LT; Lin Y; Sexton PM; Christopoulos A J Pharmacol Exp Ther; 2005 Jan; 312(1):382-90. PubMed ID: 15333678 [TBL] [Abstract][Full Text] [Related]
9. The allosteric site regulates the voltage sensitivity of muscarinic receptors. Hoppe A; Marti-Solano M; Drabek M; Bünemann M; Kolb P; Rinne A Cell Signal; 2018 Jan; 42():114-126. PubMed ID: 29056499 [TBL] [Abstract][Full Text] [Related]
10. FRET-based detection of M1 muscarinic acetylcholine receptor activation by orthosteric and allosteric agonists. Markovic D; Holdich J; Al-Sabah S; Mistry R; Krasel C; Mahaut-Smith MP; Challiss RA PLoS One; 2012; 7(1):e29946. PubMed ID: 22272263 [TBL] [Abstract][Full Text] [Related]
11. Testing the specificity of allosteric modulators of muscarinic receptors in phylogenetically closely related histamine H1-receptors. Franken C; Tränkle C; Mohr K Naunyn Schmiedebergs Arch Pharmacol; 2000 Feb; 361(2):107-12. PubMed ID: 10685864 [TBL] [Abstract][Full Text] [Related]
12. Using a radioalloster to test predictions of the cooperativity model for gallamine binding to the allosteric site of muscarinic acetylcholine M(2) receptors. Tränkle C; Weyand O; Schröter A; Mohr K Mol Pharmacol; 1999 Nov; 56(5):962-5. PubMed ID: 10531401 [TBL] [Abstract][Full Text] [Related]
13. A novel multivalent ligand that bridges the allosteric and orthosteric binding sites of the M2 muscarinic receptor. Steinfeld T; Mammen M; Smith JA; Wilson RD; Jasper JR Mol Pharmacol; 2007 Aug; 72(2):291-302. PubMed ID: 17478612 [TBL] [Abstract][Full Text] [Related]
14. Development of a radioligand, [(3)H]LY2119620, to probe the human M(2) and M(4) muscarinic receptor allosteric binding sites. Schober DA; Croy CH; Xiao H; Christopoulos A; Felder CC Mol Pharmacol; 2014 Jul; 86(1):116-23. PubMed ID: 24807966 [TBL] [Abstract][Full Text] [Related]
15. Allosteric small molecules unveil a role of an extracellular E2/transmembrane helix 7 junction for G protein-coupled receptor activation. Jäger D; Schmalenbach C; Prilla S; Schrobang J; Kebig A; Sennwitz M; Heller E; Tränkle C; Holzgrabe U; Höltje HD; Mohr K J Biol Chem; 2007 Nov; 282(48):34968-76. PubMed ID: 17890226 [TBL] [Abstract][Full Text] [Related]
16. Structure-function studies of allosteric agonism at M2 muscarinic acetylcholine receptors. May LT; Avlani VA; Langmead CJ; Herdon HJ; Wood MD; Sexton PM; Christopoulos A Mol Pharmacol; 2007 Aug; 72(2):463-76. PubMed ID: 17525129 [TBL] [Abstract][Full Text] [Related]
17. Two-state models and the analysis of the allosteric effect of gallamine at the M2 muscarinic receptor. Ehlert FJ; Griffin MT J Pharmacol Exp Ther; 2008 Jun; 325(3):1039-60. PubMed ID: 18305010 [TBL] [Abstract][Full Text] [Related]
18. Activation of muscarinic acetylcholine receptors via their allosteric binding sites. Jakubík J; Bacáková L; Lisá V; el-Fakahany EE; Tucek S Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8705-9. PubMed ID: 8710935 [TBL] [Abstract][Full Text] [Related]
19. New insight into active muscarinic receptors with the novel radioagonist [³H]iperoxo. Schrage R; Holze J; Klöckner J; Balkow A; Klause AS; Schmitz AL; De Amici M; Kostenis E; Tränkle C; Holzgrabe U; Mohr K Biochem Pharmacol; 2014 Aug; 90(3):307-19. PubMed ID: 24863257 [TBL] [Abstract][Full Text] [Related]
20. Allosteric modulation in monomers and oligomers of a G protein-coupled receptor. Shivnaraine RV; Kelly B; Sankar KS; Redka DS; Han YR; Huang F; Elmslie G; Pinto D; Li Y; Rocheleau JV; Gradinaru CC; Ellis J; Wells JW Elife; 2016 May; 5():. PubMed ID: 27151542 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]